Qualigen Therapeutics, Inc. QLGN

Set alert

Price alert · QLGN

All alert types
3.21 0.00 0.00%

At close · Nov 18

2.86 Day range 3.34
3.34 52-week range 30.50
YTD
-23.75%
1 year
-11.81%
Open
2.98
Prev close
3.21
Mkt cap
2.98M
Vol
368.77K
Avg vol
92.24K
EPS
3,635.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.86
High
3.34
Forward P/E
-4.04
Beta
0.14
Short ratio
0.11
Inst. own
1.77%
Dividend
0.00
Ex-div date
Earnings
May 7, 2024
50-d avg
5.21
200-d avg
10.89
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for QLGN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-33.02 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2016: -16573×FY 2017: -2933×FY 2018: -3319×FY 2019: -741×FY 2020: -189×FY 2021: -87.7×FY 2022: -11.8×FY 2023: -11.2×FY 2024: -0.2×FY 2025: -0.4×
FY 2016 5y median -11.2× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 2360×FY 2018: 686×FY 2019: 238×FY 2020: 894×FY 2021: 278×FY 2022: 49.6×FY 2023: 26.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 26.8× FY 2025
P/B 0.2×
FY 2016: 74249×FY 2017: 1146×FY 2018: 424×FY 2019: 1203×FY 2020: 211×FY 2021: 94.7×FY 2022: 34.2×FY 2023: -66.3×FY 2024: 0.6×FY 2025: 0.2×
FY 2016 5y median 0.6× FY 2025
P/FCF -1.0×
FY 2016: -20021×FY 2017: -3115×FY 2018: -298×FY 2019: 0.0×FY 2020: -387×FY 2021: -106×FY 2022: -18.2×FY 2023: -13.5×FY 2024: -0.2×FY 2025: -1.0×
FY 2016 5y median -13.5× FY 2025
EV/EBITDA 0.9×
FY 2016: -16575×FY 2017: -2933×FY 2018: -5534×FY 2019: -1030×FY 2020: -348×FY 2021: -69.6×FY 2022: -17.8×FY 2023: -12.4×FY 2024: -0.1×FY 2025: 0.9×
FY 2016 5y median -12.4× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 2357×FY 2018: 685×FY 2019: 238×FY 2020: 889×FY 2021: 275×FY 2022: 49.4×FY 2023: 27.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 27.0× FY 2025
FCF Yield -100.2%
FY 2016: -0.0%FY 2017: -0.0%FY 2018: -0.3%FY 2019: 0.0%FY 2020: -0.3%FY 2021: -0.9%FY 2022: -5.5%FY 2023: -7.4%FY 2024: -415.7%FY 2025: -100.2%
FY 2016 5y median -7.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 19.2%FY 2018: 6.5%FY 2019: 28.4%FY 2020: -66.9%FY 2021: 23.4%FY 2022: 13.7%FY 2023: -0.1%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: -159.1%FY 2018: -18.2%FY 2019: -27.0%FY 2020: -294.4%FY 2021: -400.9%FY 2022: -360.0%FY 2023: -217.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -217.2% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: -80.4%FY 2018: -20.7%FY 2019: -32.2%FY 2020: -474.2%FY 2021: -316.6%FY 2022: -422.1%FY 2023: -257.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median -257.8% FY 2025
ROE -69.9%
FY 2016: -448.1%FY 2017: -39.1%FY 2018: -12.8%FY 2019: -162.5%FY 2020: -111.6%FY 2021: -108.0%FY 2022: -290.7%FY 2023: 637.8%FY 2024: -229.9%FY 2025: -69.9%
FY 2016 5y median -108.0% FY 2025
ROIC -47.0%
FY 2016: -892.3%FY 2017: -74.9%FY 2018: -9.6%FY 2019: -125.2%FY 2020: -66.4%FY 2021: -123.6%FY 2022: -162.1%FY 2023: 1404.9%FY 2024: -215.1%FY 2025: -47.0%
FY 2016 5y median -123.6% FY 2025
ROA -62.4%
FY 2016: -254.0%FY 2017: -34.4%FY 2018: -7.8%FY 2019: -63.9%FY 2020: -70.1%FY 2021: -78.4%FY 2022: -110.2%FY 2023: -659.9%FY 2024: -131.4%FY 2025: -62.4%
FY 2016 5y median -110.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -40.6%FY 2019: -4.2%FY 2020: -22.5%FY 2021: 31.3%FY 2022: -11.9%FY 2023: 4.4%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -129.1%
FY 2016: -108.4%FY 2017: 57.5%FY 2018: 93.2%FY 2019: -42.5%FY 2020: -743.5%FY 2021: -78.7%FY 2022: 20.8%FY 2023: 37.0%FY 2024: 49.0%FY 2025: -129.1%
FY 2016 FY 2025
EPS (diluted) 53.1%
FY 2016: 34.4%FY 2017: 31.3%FY 2018: 83.9%FY 2019: -26.1%FY 2020: -176.8%FY 2021: 22.7%FY 2022: 10.2%FY 2023: 55.1%FY 2024: -602.4%FY 2025: 53.1%
FY 2016 FY 2025
Free Cash Flow -9.9%
FY 2016: -165.2%FY 2017: 51.3%FY 2018: -80.1%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -49.2%FY 2022: 8.8%FY 2023: 24.0%FY 2024: 38.6%FY 2025: -9.9%
FY 2016 FY 2025

Financial Health

Current Ratio 9.3×
FY 2016: 2.3×FY 2017: 8.4×FY 2018: 2.6×FY 2019: 1.3×FY 2020: 2.7×FY 2021: 4.5×FY 2022: 1.3×FY 2023: 0.3×FY 2024: 2.3×FY 2025: 9.3×
FY 2016 5y median 2.3× FY 2025
Quick Ratio 9.3×
FY 2016: 2.3×FY 2017: 8.0×FY 2018: 2.4×FY 2019: 1.3×FY 2020: 2.6×FY 2021: 4.3×FY 2022: 1.1×FY 2023: 0.3×FY 2024: 2.3×FY 2025: 9.3×
FY 2016 5y median 2.3× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.2×FY 2023: -0.6×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.5×
FY 2016: 0.4×FY 2017: 2.8×FY 2018: 8.1×FY 2019: 1.2×FY 2020: 2.1×FY 2021: 0.7×FY 2022: 0.1×FY 2023: -0.1×FY 2024: 0.2×FY 2025: 1.5×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -13.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -5.3×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -522×FY 2023: -7.4×FY 2024: -6.3×FY 2025: -13.4×
FY 2016 5y median -7.4× FY 2025

Dividends

Dividend Yield 37.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 5.8%FY 2025: 37.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio -13.1%
FY 2016: 0.0%FY 2017: -39.6%FY 2018: -0.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -1.4%FY 2025: -13.1%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31